Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled, Randomized, Single-Blind, Multi-Center Pivotal Clinical Study Using Angiotech CVC to Prevent Bacterial Colonization on Short-Term Central Venous Catheters

NCT00288418 is registered in ClinicalTrials.gov with Angiotech Pharmaceuticals as lead sponsor.

NCT NCT00288418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00288418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled, Randomized, Single-Blind, Multi-Center Pivotal Clinical Study Using Angiotech CVC to Prevent Bacterial Colonization on Short-Term Central Venous Catheters
Lead sponsor
Angiotech Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2005
Completion date
July 31, 2007
Enrollment
960 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections